Damaged gene FBXO28 is linked to patient at TGen’s Center for Rare Childhood DisordersContinue reading→

The House of Representatives on July 17, 2018  passed two bills  designed to better equip job creators in our state to grow and thrive.Continue reading→

Potentially deadly NAFLD associated with genetic changes; potential drug targets identifiedContinue reading→

New donations support research into this fast-moving brain cancerContinue reading→

 Evan Unger, MD, President and CEO of NuvOx Pharma, announced that NuvOx has received a $2M Phase II Small Business Innovation Research (SBIR) grant from the National Cancer Institute to fund the development of a new strategy to detect pancreatic cancer. Continue reading→

One of the largest medical technology companies in the world will be the first tenant for the new I.D.E.A. Tempe campus.  The Peripheral Intervention business of BD (Becton, Dickinson and Company) will be the first tenant in a new building at the Tempe Town Lake development. It will open in late 2019. Continue reading→

Mary O’Reilly, Ph.D., a philanthropy executive with extensive industry and laboratory experience, has been named the new Vice President, Bioscience Research Programs at the Flinn Foundation, where she will help implement grantmaking programs and other activities designed to advance Arizona’s bioscience sector.Continue reading→

GammaTile Therapy is the Next Step in the Expansion of Cesium to Additional MarketsContinue reading→